Home / Journals American Journal of Internal Medicine / Autologous Platelets-Rich Plasma Therapy for Hair Loss: Myth or Reality?
Autologous Platelets-Rich Plasma Therapy for Hair Loss: Myth or Reality?
Submission DeadlineFeb. 20, 2020

Submission Guidelines: http://www.sciencepublishinggroup.com/home/submission

Lead Guest Editor
Zeyad Albadri
Clinical and Experimental Medicine, Faculty of Health Sciences,Linköping University, Jönköping, Sweden
Guest Editor
  • Reem Almousali
    Family Medicine,Öxnehaga Medical Center, Jönköping, Sweden
Introduction
Hair loss has a significant influence on psychological distress and is associated with low self-esteem and depression. Androgenic alopecia is a common, chronic hair loss disorder. It is characterized by progressive hair loss, affecting both sexes. It affects up to 80% of white men and 40% of women. Men are more likely to accept hair loss but woman finds it distressing. Treatment options for androgenic alopecia are very limited and include topical minoxidil and oral finasteride (FDA approved) either alone or in combination which are FDA approved. Autologous platelets-rich plasma (PRP) has attracted a lot of attention in many different medical fields in the last decade. PRP has been used to promote healing and hair growth. In this special issue we would like to focus on the use of PRP in hair loss and its effect on promoting hair growth through a review and a case report.
Aims and Scope:
  1. Hair loss
  2. PRP
  3. Skin diseases
  4. Androgenetic alopecia
  5. Hair growth
  6. Cosmetic dermatology
Guidelines for Submission
Manuscripts should be formatted according to the guidelines for authors
(see: http://www.sciencepublishinggroup.com/journal/guideforauthors?journalid=252).

Please download the template to format your manuscript.

ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186